STAG1, as an important CAG TF, was comprehensively explored in the transcriptional regulatory mechanisms of blood vessel development and the mitotic cell cycle process in HCC, where EPAS1 may be a drug‐treatment target for HCC treatment. This evidence concerns the gene TF and hepatocellular carcinoma.